Canafenib/Encorafenib Laos generic drug purchasing channels and price analysis
Canafenib (also known as Encorafenib) is a targeted drug targeting BRAF mutations. It is mainly used to treat patients with advanced melanoma and some colorectal cancers carrying BRAF V600E mutations. Since the drug has just been launched in China and the market supply is limited, many patients will pay attention to how to obtain it through overseas channels, especially the generic versions with obvious price differences.
Currently, canafenib has been officially launched in Europe, with common specifications of 75mg*42 tablets and 75mg*168 tablets. Among them, the price of 42 capsules is more than 10,000 yuan, and the price of 168 capsules is as high as 40,000 yuan. For patients who take medicine for a long time, the financial pressure is extremely great. In addition, the price will also be affected by exchange rate fluctuations and sales channels, and the actual payment amount may be different.

In terms of generic drugs, the Lao version of canafenib has been approved by the local health department for marketing. Its drug ingredients are basically the same as those of the original drug, and it is a legal and compliant version of the generic drug. Compared with the high price in Europe, the price of the Lao version of Canafenib is relatively affordable, about 4,000 yuan per box, which greatly reduces the financial burden of patients and has become the main choice for some patients.
For patients interested in purchasing Lao version of generic drugs, it is recommended to obtain them through formal overseas medical channels or certified cross-border pharmacies to avoid the risk of counterfeit or inferior drugs purchased through unknown sources. At the same time, before deciding whether to choose a generic drug, it is best to communicate with the attending doctor to ensure that the quality and efficacy of the drug can meet the treatment needs, so as to take into account economic accessibility while ensuring safety.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)